Legacy Citation Support
21 U.S.C. § 360bbb-2
This citation is not available as a current section page in the published edition on this site, but the citation remains a meaningful historical or legacy reference.
Use the current title page and nearby sections below to continue browsing Title 21. When old citations remain in crawlers, briefs, or legacy links, this page preserves the citation locally instead of sending users to a dead end.
Nearby current sections
- § 360a–2 — Susceptibility test interpretive criteria for microorganisms
- § 360b — New animal drugs
- § 360bb — Designation of drugs for rare diseases or conditions
- § 360bbb — Expanded access to unapproved therapies and diagnostics
- § 360bbb–0 — Expanded access policy required for investigational drugs
- § 360bbb–0a — Investigational drugs for use by eligible patients
- § 360bbb–1 — Dispute resolution
- § 360bbb–2 — Classification of products